Get a glimpse into our company and investor data—powered by the PitchBook Platform
SeedLATEST DEAL TYPE
$2MLATEST DEAL AMOUNT
Developer of cancer diagnostics and gene discovery technology. The company offers a technology to measure circulating tumor cells (CTCs) in cancer patients in order to develop non-invasive diagnostic testing.